Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Cardiology · Arrhythmogenic Cardiomyopathy

The Genetics of ACM: Understanding Your Mutation

At a Glance

Arrhythmogenic Cardiomyopathy (ACM) is driven by specific gene mutations that determine how the disease affects the heart. Knowing your exact mutation, such as PKP2 or DSP, helps doctors tailor your monitoring, manage exercise limits, and screen family members who may also be at risk.

Arrhythmogenic Cardiomyopathy (ACM) is not a “one-size-fits-all” condition. Because it is a genetic disease, its behavior—which side of the heart it affects, the types of symptoms you feel, and your long-term risks—is often dictated by the specific gene mutation you carry [1][2].

The Heart’s “Glue”: The Desmosome

To understand ACM, you must understand the desmosome. Think of the desmosome as the “biological glue” or “mechanical staples” that hold your heart cells together [3][4].

In a healthy heart, these staples keep cells connected even when the heart beats fast during exercise [3]. In ACM, a genetic mutation makes these staples weak or brittle [5][6]. When the heart is under stress, the cells can pull apart, leading to inflammation and the eventual replacement of muscle with scar and fat [5][7].

Common Mutations and Their “Personalities”

Research has identified several “culprit” genes. Each one tends to follow a specific pattern:

PKP2 (Plakophilin-2)

  • The Profile: This is the most common mutation found in ACM patients [8].
  • The Subtype: Typically associated with Right-Dominant ACM (classic ARVC) [8][9].
  • The Behavior: It often presents with a high number of irregular heartbeats (arrhythmias) early on, even before the heart looks structurally different on an ultrasound [8][10]. Exercise is a very strong trigger for this specific type [11].

DSP (Desmoplakin)

  • The Profile: This gene is responsible for making the “bridge” that connects different parts of the cell’s skeleton [12].
  • The Subtype: Often associated with Left-Dominant or Biventricular ACM [12][13].
  • The Behavior: Patients with DSP mutations are more likely to experience “hot phases” (chest pain episodes that look like myocarditis) and have a higher risk of developing heart failure later in life [13][14].

Other Notable Genes

  • DSG2 & DSC2: These are also “glue” genes. Mutations here can lead to severe biventricular disease, sometimes appearing at a younger age [15][16].
  • PLN (Phospholamban): This is a “non-desmosomal” gene. It affects how the heart handles calcium [17]. It is known for causing “low voltage” on an ECG and carries a high risk for heart failure [17][18].
  • FLNC (Filamin C): Another non-desmosomal gene increasingly recognized in left-dominant ACM, heavily associated with a higher risk of dangerous arrhythmias and heart failure [19][20].
  • TMEM43: A specific variation of this gene (p.S358L) is known for being highly “arrhythmogenic,” meaning it can cause dangerous heart rhythms even if the heart muscle still looks strong [11].

Genetics and the Three Subtypes

Your genetic test results help your doctor categorize your disease into one of three main subtypes:

Subtype Primary Focus Common Genetic Link
Right-Dominant (ARVC) Affects the right ventricle; the “classic” form. PKP2 [8]
Left-Dominant (ALVC) Affects the left ventricle; often missed by old tests. DSP, PLN, FLNC [19]
Biventricular Affects both sides of the heart. DSP, DSG2, DES [21]

Why Genetic Testing Matters

Knowing your specific mutation is like having a roadmap [1]. It helps your cardiologist decide:

  1. How to screen you: For example, DSP carriers need extra-careful monitoring of the left ventricle [14].
  2. How to screen your family: If a mutation is found, your siblings and children can be tested to see if they are also at risk, often before they ever feel a single symptom [22].
  3. Exercise guidelines: Some mutations (like PKP2) are much more sensitive to exercise than others [11][23].

Common questions in this guide

What is the most common gene mutation that causes ACM?
The most common mutation found in ACM patients is in the PKP2 gene. This mutation is typically associated with right-dominant ACM, also known as classic ARVC, and can trigger arrhythmias, especially during exercise.
How does a DSP mutation affect the heart?
A DSP mutation often causes left-dominant or biventricular ACM. Patients with this mutation may experience chest pain episodes that mimic myocarditis and have a higher risk of developing heart failure later in life.
Why is genetic testing important for Arrhythmogenic Cardiomyopathy?
Genetic testing identifies your specific mutation, acting like a roadmap for your care. It helps your cardiologist determine the best way to monitor your heart, set safe exercise guidelines, and identify family members who need screening.
Can the same ACM gene mutation affect family members differently?
Yes, the same genetic mutation can present differently among family members. Relatives with the exact same gene variant may experience different symptoms, varying levels of severity, or sometimes no symptoms at all.
Will my specific ACM mutation change how much I can exercise?
Yes, specific mutations respond differently to physical activity. For example, individuals with a PKP2 mutation are often much more sensitive to exercise, which means they may require stricter physical restrictions to protect their heart.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific gene was identified in my genetic test, and is it a 'pathogenic' or 'likely pathogenic' variant?
  2. 2.Does my specific mutation (e.g., PKP2 vs. DSP) make me more likely to have the right-dominant, left-dominant, or biventricular form of ACM?
  3. 3.Given my genetic profile, should we be monitoring my left ventricle more closely for signs of scarring or heart failure?
  4. 4.Is my family at risk for a similar presentation, or can the same mutation look different in my siblings or children?
  5. 5.Does my specific mutation change how much I need to restrict my exercise levels?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Desmoplakin cardiomyopathy: recent updates in natural history and management.

    Hoffman-Andrews L, Anderson OG, Owens AT

    Current opinion in cardiology 2025; (40(5)):375-380 doi:10.1097/HCO.0000000000001240.

    PMID: 40600431
  2. 2

    Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.

    Gigli M, Stolfo D, Graw SL, et al.

    Circulation 2021; (144(20)):1600-1611 doi:10.1161/CIRCULATIONAHA.121.053521.

    PMID: 34587765
  3. 3

    Desmosomes in Human Disease.

    Najor NA

    Annual review of pathology 2018; (13()):51-70 doi:10.1146/annurev-pathol-020117-044030.

    PMID: 29414250
  4. 4

    Structure and regulation of desmosomes in intercalated discs: Lessons from epithelia.

    Yeruva S, Waschke J

    Journal of anatomy 2023; (242(1)):81-90 doi:10.1111/joa.13634.

    PMID: 35128661
  5. 5

    How ARVC-Related Mutations Destabilize Desmoplakin: An MD Study.

    Daday C, Mateyka LM, Gräter F

    Biophysical journal 2019; (116(5)):831-835 doi:10.1016/j.bpj.2019.01.023.

    PMID: 30773294
  6. 6

    Desmoplakin Haploinsufficiency Underlies Cell-Cell Adhesion Failure in DSP Cardiomyopathy and is Rescued by Transcriptional Activation.

    Smith ED, Jin K, Ferguson B, et al.

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.06.01.657304.

    PMID: 40502028
  7. 7

    Epicardial differentiation drives fibro-fatty remodeling in arrhythmogenic cardiomyopathy.

    Kohela A, van Kampen SJ, Moens T, et al.

    Science translational medicine 2021; (13(612)):eabf2750 doi:10.1126/scitranslmed.abf2750.

    PMID: 34550725
  8. 8

    Pathogenic variants in plakophilin-2 gene (PKP2) are associated with better survival in arrhythmogenic right ventricular cardiomyopathy.

    Biernacka EK, Borowiec K, Franaszczyk M, et al.

    Journal of applied genetics 2021; (62(4)):613-620 doi:10.1007/s13353-021-00647-y.

    PMID: 34191271
  9. 9

    New Variant in Placophilin-2 Gene Causing Arrhythmogenic Myocardiopathy.

    Caimi-Martinez F, Antoniutti G, Blanco R, et al.

    Genes 2022; (13(5)) doi:10.3390/genes13050782.

    PMID: 35627167
  10. 10

    Disruption of Ca2+i Homeostasis and Connexin 43 Hemichannel Function in the Right Ventricle Precedes Overt Arrhythmogenic Cardiomyopathy in Plakophilin-2-Deficient Mice.

    Kim JC, Pérez-Hernández M, Alvarado FJ, et al.

    Circulation 2019; (140(12)):1015-1030 doi:10.1161/CIRCULATIONAHA.119.039710.

    PMID: 31315456
  11. 11

    Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy.

    Paulin FL, Hodgkinson KA, MacLaughlan S, et al.

    Heart rhythm 2020; (17(7)):1159-1166 doi:10.1016/j.hrthm.2020.02.028.

    PMID: 32120009
  12. 12

    DSP-Related Cardiomyopathy as a Distinct Clinical Entity? Emerging Evidence from an Italian Cohort.

    Di Lorenzo F, Marchionni E, Ferradini V, et al.

    International journal of molecular sciences 2023; (24(3)) doi:10.3390/ijms24032490.

    PMID: 36768812
  13. 13

    Desmoplakin cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy: two distinct forms of cardiomyopathy?

    Kukavica D, Trancuccio A, Arnò C, et al.

    Minerva cardiology and angiology 2022; (70(2)):217-237 doi:10.23736/S2724-5683.21.05804-X.

    PMID: 34338490
  14. 14

    Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.

    Carruth ED, Beer D, Alsaid A, et al.

    Circulation. Genomic and precision medicine 2021; (14(2)):e003302 doi:10.1161/CIRCGEN.120.003302.

    PMID: 33684294
  15. 15

    The Novel Desmin Variant p.Leu115Ile Is Associated With a Unique Form of Biventricular Arrhythmogenic Cardiomyopathy.

    Protonotarios A, Brodehl A, Asimaki A, et al.

    The Canadian journal of cardiology 2021; (37(6)):857-866 doi:10.1016/j.cjca.2020.11.017.

    PMID: 33290826
  16. 16

    Clinical features and outcome of arrhythmogenic cardiomyopathy because of a desmoglein-2 founder variant: A multicenter study.

    Fu B, Chen Z, Chen Z, et al.

    Heart rhythm 2026; doi:10.1016/j.hrthm.2026.01.053.

    PMID: 41662985
  17. 17

    Prevalence and cardiac phenotype of patients with a phospholamban mutation.

    Hof IE, van der Heijden JF, Kranias EG, et al.

    Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2019; (27(2)):64-69 doi:10.1007/s12471-018-1211-4.

    PMID: 30547415
  18. 18

    Identifying Predictors for Heart Failure Outcomes in Phospholamban p.(Arg14del)-Positive Individuals.

    van der Heide MYC, Verstraelen TE, de Brouwer R, et al.

    JACC. Heart failure 2025; (13(10)):102558 doi:10.1016/j.jchf.2025.102558.

    PMID: 40782726
  19. 19

    Myocarditis or inherited disease? - The multifaceted presentation of arrhythmogenic cardiomyopathy.

    Westphal DS, Krafft H, Biller R, et al.

    Gene 2022; (827()):146470 doi:10.1016/j.gene.2022.146470.

    PMID: 35381313
  20. 20

    The genetic architecture of Plakophilin 2 cardiomyopathy.

    Dries AM, Kirillova A, Reuter CM, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(10)):1961-1968 doi:10.1038/s41436-021-01233-7.

    PMID: 34120153
  21. 21

    Case Illustration of the Natural History of Left Dominant Arrhythmogenic Cardiomyopathy.

    Sanford CB, Fan J, Hua Y, et al.

    Ochsner journal 2024; (24(1)):62-66 doi:10.31486/toj.23.0057.

    PMID: 38510230
  22. 22

    High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy.

    Chivulescu M, Lie ØH, Popescu BA, et al.

    European heart journal 2020; (41(14)):1401-1410 doi:10.1093/eurheartj/ehz570.

    PMID: 31504415
  23. 23

    Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy.

    van Lint FHM, Hassanzada F, Verstraelen TE, et al.

    Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2023; (31(7-8)):291-299 doi:10.1007/s12471-023-01800-4.

    PMID: 37474840

This page provides educational information about ACM genetics and gene mutations. Always consult your cardiologist or a genetic counselor to interpret your specific genetic test results and determine what they mean for you and your family.

Get notified when new evidence is published on Inherited arrhythmogenic cardiomyopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.